BOCA RATON, Fla., Oct. 10 /PRNewswire-FirstCall/ -- Nabi Biopharmaceuticals will announce third quarter 2006 financial results on Wednesday, October 25, 2006, after market close. The company will host a conference call and live webcast at 4:30 p.m. ET.
The live webcast can be accessed at: http://phx.corporate-ir.net/phoenix.zhtml?p=irol- eventDetails&c=100445&eventID=1399547 or via the Nabi Biopharmaceuticals website at http://www.nabi.com. If you do not have Internet access, the U.S./Canada call-in number is 866-277-1182 conference code 73651534, and the international call-in number is 617-597-5359 conference code 73651534. An audio replay will be available for U.S./Canada callers at 888-286-8010 conference code 57282531, and for international callers at 617-801-6888 conference code 57282531.
An archived version of the webcast will be available at the same Internet address through November 1, 2006. The audio replay will also be available through November 1, 2006. The press release will be available on the company’s website at http://www.nabi.com.
About Nabi Biopharmaceuticals
Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop and market products that fight serious medical conditions. The company has three products on the market today: PhosLo(R) (calcium acetate), Nabi-HB(R) [Hepatitis B Immune Globulin (Human)], and Aloprim(TM) (allopurinol sodium) for Injection. Nabi Biopharmaceuticals is focused on developing products that address unmet medical needs and offer commercial opportunities in our core business areas: hepatitis and transplant, kidney disease (nephrology), Gram-positive bacterial infections and nicotine addiction. For a complete list of pipeline products, please go to: http://www.nabi.com/pipeline/index.php. The company is headquartered in Boca Raton, Florida. For additional information about Nabi Biopharmaceuticals, please visit our website: http://www.nabi.com.
Nabi Biopharmaceuticals
CONTACT: Thomas E. Rathjen, Vice President, Investor Relations of NabiBiopharmaceuticals, +1-561-989-5800
